Pulse Biosciences, Inc - Common Stock (NQ:PLSE)

48.75 -1.75 (-3.47%)

Delayed Quote Updated: 10:37 AM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pulse Biosciences, Inc - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

PULSE ALERT: Bragar Eagel & Squire, P.C. is Investigating Pulse Biosciences, Inc. on Behalf of Pulse Stockholders and Encourages Investors to Contact the Firm

February 11, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

The Law Offices of Frank R. Cruz Continues Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors

February 11, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 10, 2022

Gainers Dermata Therapeutics (NASDAQ:DRMA) shares moved upwards by 26.1% to $1.35 during Thursday's regular session. The current volume of 17.5 million shares is 7266....

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

January 18, 2022

Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a...

Via Benzinga

Bronstein, Gewirtz & Grossman, LLC Notifies Pulse Biosciences, Inc. (PLSE) Investors of Investigation

February 10, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Bronstein, Gewirtz & Grossman, LLC Notifies Pulse Biosciences, Inc. (PLSE) Investors of Investigation

February 09, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors

February 08, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

51 Biggest Movers From Yesterday ↗

February 09, 2022

Also check out this: Apple And 3 Other Stocks Sold By Insiders Losers SelectQuote, Inc. (NYSE: SLQT) shares tumbled 47.3% to close at $3.44 on Tuesday after the company...

Via Benzinga

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors

February 08, 2022

From Law Offices of Howard G. Smith

Via Business Wire

Mid-Afternoon Market Update: Nasdaq Surges 100 Points; Graham Shares Plunge ↗

February 08, 2022

US stocks extended gains later in the session, with the Nasdaq index surging 100 points on Tuesday.

Via Benzinga

The Law Offices of Frank R. Cruz Announces Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors

February 08, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

What Is Happening With Pulse Biosciences Stock Today? ↗

February 08, 2022

Pulse Biosciences Inc (NASDAQ: PLSE) shares are tumbling after announcing an update to its recent FDA 510(k) submission to add sebaceous hyperplasia to expand the...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 08, 2022

Gainers BioCardia (NASDAQ:BCDA) stock inc...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

February 08, 2022

Tuesday's session saw 109 companies set new 52-week lows. Interesting Points From Today's 52-Week Highs And Lows: The largest company in terms of market cap...

Via Benzinga

Mid-Day Market Update: Pfizer Sales Miss Expectations; Teradata Shares Spike Higher ↗

February 08, 2022

US stocks remained mostly higher on Tuesday, while the S&P 500 traded lower by 0.1%.

Via Benzinga

35 Stocks Moving In Tuesday's Mid-Day Session ↗

February 08, 2022

Gainers Society Pass Incorporated (NASDAQ: SOPA) gained 63.4% to $3.45 after dropping 16% on Monday. American Rebel Holdings, Inc. (NASDAQ: AREB) climbed 56.1% to $3.45 following...

Via Benzinga

Mid-Morning Market Update: Markets Mostly Higher; Dow Rises 100 Points ↗

February 08, 2022

US stocks opened mostly higher this morning, with the Dow Jones adding more than 100 points on Tuesday.

Via Benzinga

Pulse Biosciences Provides an Update on Recent FDA 510(k) Submission

February 08, 2022

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

February 01, 2022

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Announces Preliminary Fourth Quarter and Full Year 2021 Financial and Operational Results

January 11, 2022

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences to Participate in the Stephens Annual Investment Conference

November 18, 2021

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Reports Third Quarter 2021 Financial Results

November 15, 2021

From Pulse Biosciences, Inc.

Via Business Wire

The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More ↗

November 14, 2021

Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at...

Via Benzinga

Pulse Biosciences to Present at the Stifel 2021 Virtual Healthcare Conference

November 04, 2021

From Pulse Biosciences, Inc.

Via Business Wire

Earnings Scheduled For November 15, 2021 ↗

November 15, 2021

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third quarter. • Tyson Foods (NYSE:TSN) is estimated to...

Via Benzinga

Pulse Biosciences Schedules Third Quarter 2021 Financial Results Conference Call for November 15, 2021

November 02, 2021

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Appoints Laureen DeBuono to Its Board of Directors

October 05, 2021

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences to Participate in the H.C. Wainwright Global Investment Conference

September 02, 2021

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Announces Appointment of Mitchell E. Levinson as Chief Strategy Officer

August 19, 2021

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Reports Second Quarter 2021 Financial Results

August 09, 2021

From Pulse Biosciences, Inc.

Via Business Wire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.